A revolutionary, solvent-free extraction technology delivering industry-leading yields, unmatched terpene preservation, and dramatically lower costs — positioned to become the standard in Cannabis oil extraction.
Our patent-pending process isolates cannabinoids, terpenes, and trichomes without thermal degradation or solvent use — delivering results that conventional systems simply cannot match.
Zero chemical solvents used throughout the entire extraction cycle. Produces plant-derived, non-synthetic cannabinoids with full compound integrity.
Achieve 2–9% extraction yields compared to the industry standard of 2%, delivering more product from every batch of biomass processed.
Retains 9–11% terpenes — preserving the full spectrum of flavor, aroma, and therapeutic cannabinoid profiles that consumers demand.
Custom-engineered proprietary equipment built for scalability, consistency, and efficiency. Developed by industry-leading extraction engineers.
Significantly reduced capital and operating expenses versus conventional multi-million-dollar extraction setups, enabling faster ROI.
Operates without high-heat processing, ensuring zero thermal degradation and maintaining the full potency of extracted compounds.
Three to four fully licensed facilities — each fully licenced to grow, cultivate, process, extract, package, white label, and distribute premium cannabis oil-based products.
Already operational with capacity to rapidly capture majority market share within the proposed timeframe. First-mover advantage in a mature regulated market. Michigan has the highest smoking and consumption of cannabis per capita population in the USA.
A large, emerging adult-use market with limited supply of premium oil products. Significant first-mover opportunity for high-quality extraction.
The facility is designed to serve international medical markets, including Germany, the UK, and Australia. It currently supplies EU GMP-compliant cannabis flower to over 80 countries and is among the few licensed facilities with the capability to ship compliant flower globally. There is active global demand from customers seeking to purchase bulk oil and oil-based products, as well as white-label finished goods tailored to each destination.
Positioned to become one of the largest cannabis markets in the United States. Key long-term growth driver with massive consumer demand trajectory.
Each distribution center generates revenue from multiple, complementary business lines — maximizing utilization and de-risking the overall model.
The Canadian legal cannabis vape segment continues to show strong expansion. Revenue generated approximately $315M in 2024 and is expected to reach approximately $695M by 2030, representing continued robust growth and consumer demand.
Vape products represent a growing share of legal cannabis sales, with inhaled extracts increasing as a segment over multiple reporting years.
The Continuing Appropriations and Extensions Act of 2026 bans synthetic hemp-derived cannabinoids effective November 12, 2026 — accelerating our pathway to profitability and creating unprecedented market opportunity.
The Continuing Appropriations and Extensions Act of 2026 excludes from "legal hemp" any cannabinoids that are "synthesised or manufactured outside the cannabis plant" — closing the loophole that allowed CBD to be converted into delta-8, delta-10, and other synthetic cannabinoids.
A federal ban on intoxicating, hemp-derived products takes effect, restricting hemp products to no more than 0.4mg of total THC per container. Any product exceeding this limit becomes a Schedule I controlled substance.
This reclassification is expected to make roughly 95% of current hemp products illegal — dismantling the "gas station weed" market and forcing consumer demand back into fully licensed cannabis frameworks.
Our extraction process produces plant-derived, non-synthetic cannabinoids in compliant, licensed facilities — representing one of the most cost-effective and defensible ways to supply cannabis oil in a post-hemp regulatory environment.
The DOJ is targeting all converted oil products derived from hemp. By November 2026, this massive market will be forced back into the licensed cannabis framework — creating an unprecedented demand surge for compliant, plant-derived cannabis oil producers like us.
Each distribution center targeted to be fully operational and profitable
Annual profit per distribution center within the stated timeframe
Highly repeatable and scalable model across domestic and international markets
Seeking strategic partners and investors who can support the phased development of our platform with attractive 8–12% yield year over year from inception.
Continue build-out to accelerate market capture and fully operational status.
Acquire and build out a Canadian center for the regulated market — vape pens and extract products.
Build out four additional centers, each projected to generate ~$25M/year in profit.
With patent-pending technology, proprietary machinery, strong regulatory alignment, and a vertically integrated model — this platform is uniquely positioned for industry-defining growth.